A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires
CytoDyn Inc () has announced encouraging early data from its long-hauler CD15 trial, which aimed to assess leronlimab administered as a weekly injection in people experiencing COVID-19 (coronavirus) symptoms for over 12 weeks. “We are very pleased with the preliminary results from our long-haulers trial, which showed a greater improvement in the leronlimab patient group over placebo in 18 of 24 COVID-19 symptoms,” said Chris Recknor, CytoDyn’s chief operating officer. Nader Pourhassan, CytoDyn’s CEO, noted that before the trial had begun, the FDA had advised that the long-haulers trial was considered an exploratory trial, thus a follow-on trial would be necessary prior to potential approval. “Our hope, following the FDA’s review of all data, is that the agency will grant us a Breakthrough Therapy designation and provide guidance for a Phase 3 trial protocol,” he said.
Progressive Planet Solutions Inc (CVE:PLAN) announced it has hired Dr Roger Mah as its vice president of research and development. Mah, who has a PhD in chemistry from the University of Calgary, was previously CEO of ZoraMat Solutions, where he led efforts in commercializing a metal-organic framework for carbon capture.
(NYSEAMERICAN:AIM) has announced that all subjects have completed treatment in the Phase 1 clinical study to assess the safety, tolerability, and biological activity of its flagship drug Ampligen as a potential intranasal therapy. The Ocala, Florida-based immuno-pharma company said a final study report is expected in the third quarter of 2021. A total of 40 healthy subjects received either Ampligen or a placebo in the trial, with the Ampligen given at four escalating dosages across four cohorts, to a maximum level of 1,250 micrograms. The study reported no severe adverse events at any dosage level. The company is now moving forward with the initial planning and negotiations for a follow-up Phase 2 study testing Ampligen as a potential broad-spectrum respiratory virus prophylaxis. “This Phase 2 study will test this proposition in humans. A successful Phase 2 study could also establish Ampligen as a potential prophylaxis against future viral variants and future novel respiratory viruses for which there are no current therapies.”
() (OTCMKTS:AZASF) said it has entered into an agreement with Dig Media Inc.’s Investing News Network (INN), to provide marketing and advertising and investor awareness services to the corporation for the purposes of raising awareness and the development of its flagship Projects. INN is a private company headquartered in Vancouver, Canada, headed by Michael Ralph Rodger and is dedicated to providing independent news and education to investors since 2007. INN , which has been retained for a term of 12 months expiring on June 21, 2022, will be paid a fee of C$30,000 (plus GST) and has been granted options to purchase up to 97,560 common shares of the corporation, with an exercise price of C$0.205 per share that will have a life of 2 years from the date of issue, with vesting restrictions in accordance with TSX Venture Exchange policies. The agreement with INN and the grant of stock options are subject to the approval of the exchange.
Delta 9 Cannabis Inc () (OTCQX:DLTNF) has announced the launch of its “Joints for Jabs” vaccination reward program to encourage Manitobans to become fully vaccinated with two doses of a coronavirus (COVID-19) vaccine. Starting today (June 21), the company said people who have received two doses of a COVID-19 vaccine are eligible to enter into a rewards program at every Delta 9 Cannabis store location in Manitoba. “We want to encourage all Manitobans to get vaccinated as soon as possible to help ensure that we can all get back to doing the things we love with our friends and family,” said Delta 9 CEO John Arbuthnot in a statement. “Our hope is that the ‘Joints for Jabs’ program will contribute to achieve this objective.”
. () has announced the start of a $5.6 million bulk sampling program at its Naujaat Diamond Project in Nunavut, Canada. In an update, the Vancouver-based exploration company said field crews have arrived on site and preparations are underway for the start of sample collection during the first week of July. The program, scheduled to run through the end of August, will involve the collection of up to 2,000 tonnes from the Q1-4 kimberlite.
Empower Clinics Inc () (FRA:8EC) () has signed a Memorandum of Understanding (MOU) for a six-month pilot program with Pharmachoice for the distribution and resale of Kai Care COVID-19 testing solutions. Empower said the products will include Rapid Antigen testing, Rapid Antibody testing, and Saliva RT-PCR tests. Under a MOU, Empower and Pharamchoice have agreed to the six-month pilot program to allow both parties to fully evaluate revenue, marketing, and partnership expansion opportunities. The goal is to determine the optimal business model that will best serve PharmaChoice and its patients.
() (OTCPINK:NBMFF) has announced that its silicon (Si) nanocoating technology is highly effective in conventional graphite/Si mixture anodes, overcoming a major barrier to the commercialization of Si anodes in graphite anode systems. The Vancouver-based resource company said testing was conducted and validated by a well-established third-party laboratory in South Korea. NEO is focused on battery metal exploration in North America, focusing on developing silicon anodes through nanocoating an ion-conductive elastomer layer, which provides improvements in capacity and efficiency over lithium-ion batteries using graphite in its anode materials. The company intends to become an integrated silicon producer and anode materials supplier to the electric vehicle industry.
Vicinity Motor Corp () () () said it has received a new purchase order from Québec private transit operator Le Groupe Transbus for its Vicinity Classic buses. Le Groupe Transbus has ordered three of the company’s 30-foot Clean-Diesel Vicinity Classic buses. The Vicinity buses are in service with Canadian public transit agency EXO, serving the city of Varennes, a suburb of Montreal. Transbus currently owns and operates nine Vicinity Classic buses, and with this order, takes the total to 12 in its fleet.
Inc () () (FRA:JAM1), has announced that its investigational new drug ARDS-003 studied in a viral-infected organoid model as part of a research collaboration between Targeted Pharmaceuticals and George Mason University, has revealed new antiviral properties. Derived from cannabinoids, ARDS-003 is designed to prevent and treat acute respiratory distress syndrome (ARDS), a severe inflammatory response that could be life-threatening to patients with coronavirus (COVID-19) or sepsis. On March 26, 2021, Tetra said it had struck an agreement with Targeted Pharmaceuticals to initiate additional studies on ARDS-003. “As a result, a preliminary study on HIV using the HU-308 molecule, the active pharmaceutical ingredient used in our COVID-19 therapeutic ARDS-003, determined that viral replication is significantly decreased when HU-308 is used in combination with a standard antiviral drug to treat HIV,” said the company.
Ltd () () (FRA:GDT) has officially started the commercial launch of SekurMessenger — its Swiss-hosted messaging security and privacy solution — in Latin America. The company in January had announced it would be launching SekurMessenger, which offers encrypted instant messaging, secure voice recording transfer, and secure file transfer, with América Móvi’s Telcel mobile operator in Mexico. GlobeX said the secure messaging service has been fully integrated with Telcel’s billing and provisioning platform and the company has performed sales training to Telcel’s corporate sales managers and is already receiving requests for the solution.
Ltd () () (FRA:7HIA) announced it has secured a product development laboratory and testing facility in Vancouver for its electric vehicle (EV) initiatives. The Canadian clean technology company is working on two innovations in the EV space through a collaboration with Germany’s Systematec GmbH, a specialist engineering developer and component designer to major EV and electrical equipment manufacturers. Hillcrest told shareholders that the team was “quickly advancing” towards proof-of-concept status.
Ltd () (OTCQB:GRLSF) (FRA:GPE) has kicked off a 14,000-metres (m) drill program on its silver properties in the Rosaria Mining District of Mexico to test new prospective high-grade veins. The company said it had mobilized seven drill rigs for the program, which will cover extensive silver-gold vein systems over a combined 75m strike length on the Plomosas, San Marcial and La Trinidad areas in the state of Sinaloa. Vancouver-based GR Silver recently wrapped up drill programs at the Plomosas and San Juan areas within the wider Plomosas Silver Project.
Midwest Energy Emissions Corp (), which is known as ME2C Environmental, has partnered with Pennsylvania State University’s College of Earth and Mineral Sciences which will evaluate the company’s rare earth element (REE) technology’s capture capacity and regeneration potential under certain conditions. ME2C Environmental said the evaluation and test period is set to run from June through to the end of September. REEs are crucial in the manufacturing of permanent magnets, which are used in wind turbines and electric vehicle engines, as well as other green applications.
MegumaGold Corp () () () has completed soil geochemistry, till sampling and prospecting at its Murchyville South option property in Nova Scotia ahead of potential drill targeting. Murchyville South comprises exploration licences previously optioned from Genius Metals Inc and this latest work is estimated to have cost more than C$100,000 – the minimum expenditure required for initial exploration, which would allow MegumaGold to earn a 9.9% interest, including related rights and data.
BioLargo Inc () has announced the publication of a peer-reviewed scientific paper that confirms the safety of water treated by its Advanced Oxidation System (AOS), an energy-efficient industrial water disinfection technology. The Westminster, California-based company said the paper, which focused on quantifying the disinfection by-products generated by the AOS, represents a “critical milestone” in the commercialization of the company’s “innovative” water treatment technology. BioLargo noted that its ground-breaking AOS technology provides high-level disinfection and consumes less electricity than competing technologies such as UV and ozone-based systems. Significantly, the AOS removes pharmaceutical micropollutants from water to provide added value across diverse water treatment applications, including municipal wastewater treatment.
Ltd () (OTCQX:GTBAF) (FRA:0G6A) said it was approaching the completion of a 50-hole drill program on the LP Fault zone, at the Dixie project in the Red Lake district of Ontario. The drilling is part of the larger fully-funded $45 million exploration program that is ongoing at the company’s flagship Dixie project. According to Great Bear, the site hosts two principal styles of gold mineralization, high-grade gold in quartz veins and three silica-sulphide replacement zones (the Dixie Limb, Hinge and Arrow).
Inc. () () (FRA:7LV) has announced that it has closed its acquisition of US company Green Roads, as well as its manufacturing subsidiary as it expands its business globally. Valens will pay US$40 million for Green Roads, plus up to an additional US$20 million in contingent consideration payable upon the purchased business achieving certain profit milestones. If all the milestones are met, the transaction represents around 4.5x 2022 earnings before interest, tax, depreciation, and amortization (EBITDA). Following the acquisition, Valens said it has a significant presence in the largest cannabinoid market in the world, representing a big step in its international expansion strategy and furthering its vision of becoming a global manufacturer of cannabis consumer packaged goods.
() (OTCPINK:MWSNF) (FRA:MXR) has said it is to receive C$590,000 (€397,000) as part of a C$1.2 million (€795,000) funding package from the Finland-based Circular Ecosystem of Battery Metals (BATCircle2.0) to help to ensure its Rajapalot gold-cobalt project becomes a significant Finnish, and European, raw material supplier to the battery metals industry. The project contains nickel, copper and tungsten, as well as gold and cobalt and the focus for many such Finnish polymetallic deposits has been to optimise gold returns over other metals. Losing battery and critical metals to tailings is a poor outcome for Finland and a circular low-carbon economy, pointed out Mawson.
Wellness Inc () () (FRA:8OO), a top CBD and probiotic supplements company, said it has promoted Maria Leal, the company’s VP and controller, to interim chief financial officer (CFO). Leal holds a CPA and an MBA and has a strong track record in financial management having served in various senior financial accounting positions during her more than 20-year career. Leal has been with since July 2019 and has been helping in every aspect of the company’s financial reporting. The Denver, Colorado-based health and wellness company thanked Bruce Valentine for his service to HempFusion. Valentine stepped down as CFO on June 16, 2021, due to the unexpected passing of his mother and the resulting duties that ensued.
() (OTCMKTS:FPOCF) (FRA:FP5) announced the appointment of Andrew Osterloh as the company’s vice-president, projects. Osterloh, former project director and manager of studies for Canada, will provide technical leadership for the continued exploration and development of FPX’s Baptiste nickel project in British Columbia.
Tartisan Nickel Corp () (OTCPINK:TTSRF) said it has closed the second tranche of its C$4.5 million flow-through financing, which was comprised of 4,526,400 flow-through company units at a price of $0.57 per unit, for total proceeds of $2,580,048. The company said proceeds from the financing will be used to fund the exploration and development of its flagship Kenbridge nickel project in northwestern Ontario. Each unit of the financing consists of one flow-through share plus one-half of one warrant, with each full warrant entitling the holder to acquire one additional company common share at a price of $0.85 per warrant share for a period of two years from the closing date.
() (OTCQB:SNWGF) has said its common shares have been approved for trading on the OTCQB Venture Market operated by the OTC Markets Group Inv. (). The company commenced trading on the OTCQB at today’s opening under the symbol SNWGF. The company’s common shares will also continue to trade on the Canadian Securities Exchange under the symbol SGD. The OTCQB is the premier venture marketplace for entrepreneurial and developing US and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, Companies must meet high financial standards, including be current in their financing reporting, follow best practice corporate governance, have a professional third-party sponsor introduction, demonstrate compliance with US securities laws, and undergo an annual verification and management certification process.
Limited (NYSEAMERICAN:VNRX) has announced that Scott Powell, EVP of Investor Relations and chief financial officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on June 24, 20231, at 1.30pm EST via the following link: https://bit.ly/3c7Ertp. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
Life Sciences Investor Forum has announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. The day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 8.45am ET on Thursday, June 24, 2021, with the first live webcast at 9.00am ET. Investors can register for the event using the following link: https://bit.ly/2P9cmZK. For more information about the program, investors can visit: www.lifesciencesinvestorforum.com.
Virtual Investor Conferences, the leading proprietary investor conference series, has announced that the presentations from the June 17, 2021, International lnvestor Conference are now available for on-demand viewing. via the following link: https://bit.ly/3zvRyP0. The company presentations will be available 24/7 for 90 days. Investors, advisors and analysts may download shareholder materials from the “virtual trade booth” for the next three weeks. A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group Inc’s () suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. To view a complete calendar of Virtual Investor Conferences, investors can visit www.virtualinvestorconferences.com.
(), the operator of financial markets for 11,000 US and global securities, has announced that () (OTCQX: BSSF), a diversified developer, manufacturer and provider of innovative survivability solutions, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. “Our decision to cross-trade in the US is part of our strategy to expand our international shareholder base, increase trading liquidity, provide a USD quote in our Shares and facilitate greater access and trading capability in our Shares for both institutional and retail investors,” said Gren Schoch, chairman and CEO of AirBoss. “It is also in response to increased interest from US and international investors in AirBoss and reflective of the composition of our business: approximately 90% of our sales in 2020 were from the US and international markets and our reporting currency is US dollars.”
(), the operator of financial markets for 11,000 US and global securities, has announced that ThreeD Capital Inc (CSE:IDK) (OTCQX:IDKFF), a Canadian based venture capital firm, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. Sheldon Inwentash, chairman and CEO of ThreeD Capital Inc. commented: “We are very proud to upgrade to the OTCQX Market. This upgrade marks an important milestone in the Company’s history as it is anticipated that this will increase the Company’s exposure within the United Sates and allow more investors to participate in the growth of our Company. In a short period of time, we have built a portfolio with early–stage investments in highly prospective companies. We are now beginning to see the early phase returns on many of these strategic investments and are excited about increasing our ability to allow American investors the opportunity to participate in ThreeD’s accelerating growth in 2021 and beyond.”